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1  |  INTRODUC TION
Coronavirus disease 2019 (COVID-19) represents a complex respi-
ratory distress syndrome which can evolve into multi-organ failure 
caused by the betacoronavirus SARS-CoV-2. Epidemiological data 
shows that COVID-19 has a rising mortality particularly in males 
with advanced age. In United States, Europe, and China, individuals 
over 60 years of age with underlying conditions such as hyperten-
sion, diabetes, cardiovascular or respiratory disease, and cancer are 
considered to be more at risk to develop severe symptoms (Chen 
et al., 2020; Control, E.C.f.D.P.a.,; Garg et al., 2020; Huang et al., 
2020; Liang et al., 2020; WHO; Zhou et al., 2020). Whether there is a 
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Abstract
SARS-CoV-2 is a novel betacoronavirus which infects the lower respiratory tract and 
can cause coronavirus disease 2019 (COVID-19), a complex respiratory distress syn-
drome. Epidemiological data show that COVID-19 has a rising mortality particularly 
in individuals with advanced age. Identifying a functional association between SARS-
CoV-2 infection and the process of biological aging may provide a tractable avenue for 
therapy to prevent acute and long-term disease. Here, we discuss how cellular senes-
cence—a state of stable growth arrest characterized by pro-inflammatory and pro-dis-
ease functions—can hypothetically be a contributor to COVID-19 pathogenesis, and a 
potential pharmaceutical target to alleviate disease severity. First, we define why older 
COVID-19 patients are more likely to accumulate high levels of cellular senescence. 
Second, we describe how senescent cells can contribute to an uncontrolled SARS-
CoV-2-mediated cytokine storm and an excessive inflammatory reaction during the 
early phase of the disease. Third, we discuss the various mechanisms by which senes-
cent cells promote tissue damage leading to lung failure and multi-tissue dysfunctions. 
Fourth, we argue that a high senescence burst might negatively impact on vaccine ef-
ficacy. Measuring the burst of cellular senescence could hypothetically serve as a pre-
dictor of COVID-19 severity, and targeting senescence-associated mechanisms prior 
and after SARS-CoV-2 infection might have the potential to limit a number of severe 
damages and to improve the efficacy of vaccinations.
K E Y W O R D S
aging, cellular senescence, COVID-19, inflammation
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functional association between SARS-CoV-2 infection and biological 
aging remains an open question.
Aging is a physiological decline of organismal functions involv-
ing numerous components. A major age-associated hallmark is the 
accumulation of cells that undergo senescence—a state of stable 
growth arrest characterized by hypersecretory functions. The hy-
persecretion is collectively defined as SASP (senescence-associated 
secretory phenotype) and includes various tissue remodeling (e.g., 
TGF-β and MMPs) and immune-related (e.g., IL-6, IL-8, and IFNs) 
factors. Via tissue remodeling SASP factors, senescent cells posi-
tively regulate tissue regeneration and repair, and help to maintain 
tissue homeostasis. Via immune-related SASP factors, senescent 
cells promote immunosurveillance, particularly in the context of 
tumorigenesis where they recruit T cells and NK cells (Prata et al., 
2018). In optimal conditions and in young organisms, senescent 
cells are only transiently present and are timely removed by either 
immune-mediated mechanisms or by transitioning to other states, 
mainly apoptosis (Childs et al., 2014). In contrast, during aging and 
chronic diseases, these events do not function properly, and senes-
cent cells persist (Munoz-Espin & Serrano, 2014). Moreover, aged 
cells become more susceptible to damage, and more likely to un-
dergo senescence (Bermúdez-Cruz & F.A.L.-R.a.R.M., 2019). These 
events contribute to a steady accumulation of senescent cells with 
age, and their initial benefit is then overtaken by detrimental func-
tions exerted by chronic secretion of SASP factors and consequent 
tissue function dysfunctions, aberrant paracrine senescence, and 
chronic inflammation. In accordance to this notion, elimination of 
senescent cells (by using so-called senotherapies) in aged and/or dis-
eased conditions is sufficient to alleviate onset and progression of 
dysfunctions and pathology (Paez-Ribes, 2019).
Interestingly, cellular senescence can be prematurely induced 
by viral infections via cell and/or non-cell autonomous mechanisms. 
Some viruses can cause DNA damage (Martinez, 2016) or cell fusion 
(Chuprin, 2013) leading to a senescence state. In addition, infected 
cells activate anti-viral responses which include the release of type 
I and III interferons (IFNs) and other pro-inflammatory mediators 
(Newton et al., 2016) upon activation of pattern recognition recep-
tors (PRRs) by pathogen-associated molecular patterns (PAMPs). 
Interestingly, prolonged exposure to IFN-γ and IL-6 has been shown 
to induce senescence in normal cells, suggesting that infected, 
but not necessarily senescent, cells might activate a senescence 
in the surrounding environment (Kandhaya-Pillai et al., 2017; Kim 
et al., 2009). Furthermore, the anti-viral cyclic GMP-AMP synthase 
(cGAS)-stimulator of interferon genes (STING) signaling pathway has 
been recently shown to regulate senescence phenotypes (Dou et al., 
2017; Hari et al., 2019). Beside these data, the fact that many viruses 
evolved proteins that can prevent infected cells from undergoing se-
nescence (Reddel et al., 2010), and senescent cells are resistant to 
some viral infections (Baz-Martinez et al., 2016) suggest that cellular 
senescence might act as an anti-viral defense mechanism and that 
the number of senescent cells is likely to be elevated in infected in-
dividuals (Figure 1).
F I G U R E  1 Potential	pathways	of	senescence	induction	as	a	consequence	of	SARS-CoV-2	Infection.	Viral	infection	can	promote	
senescence induction directly or indirectly by increasing IFNs secretion from infected cells and DAMPs release from cells undergoing 
pyroptosis or necroptosis. Senescent cells can spread senescence in the environment via SASP factors. Additionally, anti-viral mechanisms 
can activate the immune system which can further propagate senescence as a consequence of ROS and inflammatory mediators release
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SARS-CoV and SARS-CoV-2 trigger a “cytokine storm,” the 
release of an array of inflammatory cytokines and chemokines 
such as CXCL-10, CCL-2, IL-6, IL-8, IL-12, IL-1β, IFN-γ, and TNF-
α. Many of these factors have the potential to induce “paracrine” 
senescence via prolonged cytokine signaling (Acosta et al., 2013; 
Kandhaya-Pillai et al., 2017; Kim et al., 2009) (Figure 1). In addi-
tion, viral infections might propagate senescence via necropto-
sis and pyroptosis (Tang et al., 2019), two types of inflammatory 
cell death mechanisms that release danger-associated molecular 
patterns (DAMPs). SARS-CoV can activate NLRP3 inflammasome 
(Chen et al., 2019), a main inducer of pyroptotic cell death, and 
SARS-CoV-2 is thought to induce pyroptosis (Yang et al., 2020). 
DAMPs bind to PRRs and non- PRRs DAMP receptors and acti-
vate the interferon response (Gong et al., 2020), which can further 
propagate senescence (Figure 1) (Kim et al., 2009; Schuliga et al., 
2020).
In summary, older COVID-19 patients are more likely to accumu-
late high levels of cellular senescence for three reasons: (a) the num-
ber of senescent cells is already elevated at the time of infection, 
and this can increase the possibility of paracrine senescence events; 
(b) older cells are more susceptible to enter senescence because of 
their decreased capacity to repair damage. In addition, aged tissues 
are less capable to eliminate senescent cells due to, at least in part, a 
decline in immune functions (see next section).
2  |  A SSOCIATION OF CELLUL AR 
SENESCENCE WITH IMMUNE IMBAL ANCE , 
CHRONIC INFL AMMATION, AND 
E XCESSIVE IMMUNE RESPONSES
Diminished immune responses that accompany aging, a pheno-
type defined immunosenescence, can predispose the elderly 
to complications caused by viral infection (Keilich et al., 2019). 
Immunosenescence is a multifaceted phenomenon associated to a 
basal level of chronic inflammation and less effective anti-viral re-
sponses. Phenotypically, immunosenescence manifests as loss of 
naive T cells and of effector cell functionality, decreased lymphocyte 
proliferation, increased number of terminally differentiated memory 
lymphocytes and of neutrophils, and dysregulated cytokines pro-
duction. A significant correlation between age and SARS-CoV-2 viral 
load has been reported (Liu et al., 2020; To et al., 2020), and the 
presence of an immunosenescent phenotype, demonstrated by el-
evated neutrophils-to-lymphocytes ratio (NLR) (Qin et al., 2020) and 
high IL-6 production (Ulhaq & Soraya, 2020), has been correlated 
to disease severity. Changes observed in immunosenescence can 
be attributed to various cell intrinsic and extrinsic (environmental) 
factors, and cellular senescence is heavily implicated in influencing 
these factors.
Intrinsic defects related to senescence have been documented 
in adaptive immune cells with age. CD3+ T cells including the CD4/
CD8 fraction can interact with other immune cells to help stim-
ulate antibody response to infection and present an increase in 
p16INK4A expression exponentially with chronological age and 
that was associated with an increase in plasma interleukin-6 con-
centration (Liu et al., 2009). In mice, T cells that exhibit senes-
cence-like features were shown to increase with age (Tahir et al., 
2015). Interestingly, induction of mitochondrial dysfunction, a 
prominent aspect affecting many old tissues, in T cells promotes 
the acquisition of a senescence-like phenotype (Baixauli et al., 
2015). Using the same model, a recent study has shown that T cells 
with dysfunctional mitochondria have a reduced capacity to clear 
viral infections and strikingly, contributed to the accumulation of 
circulating cytokines termed “type-1 cytokine storm” that act as a 
systematic inducer of senescence in several tissues (Desdin-Mico 
et al., 2020). It is interesting to note that patients with COVID-
19 pneumonia have an increase in the proportion of T cells that 
display exhaustion/senescence markers (De Biasi et al., 2020). In 
addition to senescent-like T cells, senescent-like B lymphocytes 
also express inflammatory SASP factors that accumulate with age 
(Frasca et al., 2017) and IL-6 and TNF-α have been shown to in-
duce premature senescence in non-senescent T cells in a paracrine 
manner and are also increased in patients with severe COVID-19 
(Liu et al., 2009; Ulhaq & Soraya, 2020). Together, these results 
suggest potential implications in humans for senescence-associ-
ated immune dysfunctions, with particular relevance to viral in-
fections that partly rely on cellular immunity such as in the case 
of SARS-CoV-2.
Immunosurveillance by the innate immune system is the first 
responder to viral infections and other stresses. NKG2D ligands 
are surface proteins upregulated on viral-infected cells that act 
as key activators of NK cells and facilitate immune clearance 
(Lanier et al., 2015). It has been reported that in different models 
of stress-induced senescence in human fibroblast, including lung 
fibroblasts, and in some epithelial and tumor cells, NKG2D ligands 
are upregulated. However, a subset of senescent cells can evade 
NK cell immune detection by shedding NKG2D ligands through 
autocrine and paracrine MMP-mediated proteolytic cleavage 
(Munoz et al., 2019; Sagiv et al., 2016). Since SASP MMPs are dif-
fusible and senescent cells generally accumulate with age, early 
NK-mediated immune response to SARS-CoV-2 in the elderly 
may be blunted by a senescence-associated and MMP-mediated 
NKG2D ligand shedding from infected cells, leading to impaired 
SARS-CoV-2 clearance.
Dendritic cells (DCs) have an important role in bridging innate and 
adaptive immunity. In the lungs, DCs reside in an “immature” state 
until they recognize and capture inhaled materials. Upon capturing 
antigens, in addition to the presence of proper stimulation, DCs mi-
grate to draining regional lymphoid tissues, where they play a crucial 
role for activation of naïve T cells (Condon et al., 2011). The ability 
of DCs to migrate from the site of infection to the lymph nodes in 
response to many respiratory viral infections, including SARS-CoV, 
is considerably impaired with increasing age, resulting in diminished 
T-cell responses (Zhao et al., 2011). Interestingly, impaired DC migra-
tion has been shown to be mediated, in part, by increased levels of 
the lipid mediator prostaglandin D2 (PGD2) in the respiratory tract 
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with age (Zhao et al., 2011), and prostaglandins secretion is signifi-
cantly increased in senescent lung cells (Wiley et al., 2019; Zdanov 
et al., 2007). Thus, it is possible that age-associated accumulation of 
senescent cells is responsible for the increased PGD2 levels in the 
respiratory tract.
The thymus is the primary central T lymphoid organ respon-
sible for the development of naïve T cells and the establishment 
of immune tolerance. Thymic involution or regression is the most 
pronounced change in the aging immune system and seems to be 
an evolutionarily conserved process as it occurs in almost all verte-
brates (Shanley et al., 2009). Thymic involution is associated with a 
progressive decline in the production of new T lymphocytes (Petrie 
et al., 2002) which eventually leads to reduced TCR repertoire di-
versity (Goronzy et al., 2007) and decreased capacity of mounting a 
sufficient adaptive immunity in response to infection (Palmer et al., 
2018). Interestingly, cellular senescence has been linked to thymic 
involution both in mice and humans (Aw et al., 2008; Barbouti et al., 
2019; Burnley et al., 2013), and could therefore be a likely contribu-
tor to age-associated thymic inflammation and atrophy (Sempowski 
et al., 2000).
Lymph nodes (LNs) are a major site for the maintenance of 
naïve T cells (Brown & Turley, 2015). Upon aging, LNs show signs 
of morphological degeneration, changes in the histoarchitecture 
(including fibrosis), and numerical decline (Ahmadi et al., 2013; 
Hadamitzky, 2010). Subsequently, this altered tissue environment 
fails to support naïve T-cell homeostasis (Becklund et al., 2016), 
contributes to suboptimal immune defense (Thompson et al., 
2019), and compromises the priming of early adaptive immune 
responses upon viral infection (Richner et al., 2015). LNs stroma 
is populated with different subset of cells that are crucial for im-
mune regulation (Chang & Turley, 2015). Some of these cells were 
shown to have an age-related reduction in proliferation upon viral 
infection, potentially correlated to increased senescence (Masters 
et al., 2019).
The spleen is another secondary lymphoid organ that is affected 
by age. As is the case of LNs, the spleen also shows microarchitec-
ture abnormalities (Turner & Mabbott, 2017) and different publi-
cations have demonstrated that senescence-associated markers 
accumulate in the aging spleen (Baker et al., 2016; Wang et al., 
2009) with splenic stromal cells expressing high IL-6 levels (Park 
et al., 2014). Interestingly, clearing senescent cells from irradiated 
spleen can improve T-cell and macrophage functions, suggesting a 
role of senescent cells in promoting immune dysfunctions (Palacio 
et al., 2019). In accordance, different SASP factors can affect the 
response of different immune cells: TNF-α can accelerate T cells' 
replicative senescence (Parish et al., 2009) and decrease activation 
and class switching in B cells (Frasca et al., 2012), while CCL-2 ex-
pressed by stromal cells can limit antibody-forming cells (AFC) sur-
vival (Dasoveanu et al., 2020).
All of the mentioned studies implicate that cellular senescence is 
a likely contributor to the immunosenescence phenotype observed 
in aging organisms which could predispose COVID-19 patients to de-
velop severe-to-lethal pathogenesis.
3  |  CONTRIBUTION OF CELLUL AR 
SENESCENCE TO TISSUE DAMAGE
3.1  |  Contribution of senescence to lung damage/
failure
Once SARS-CoV-2 is inhaled, it is likely to first bind to ACE2 on epi-
thelial cells in the nasal cavity and start replicating. Following this 
stage, the virus propagates in the respiratory tract and triggers a 
more robust immune response. Once reaching the gas exchange 
units of the lung, SARS-CoV-2 preferentially infects alveolar type 
II cells, the larger cells involved in surfactant secretion. About 20% 
of infected patients can develop pulmonary infiltrates, and some 
of these seem to progress to severe disease (Mason et al., 2020; 
Zhao et al., 2020). Main lung pathological features of COVID-19 pa-
tients resemble those seen in SARS and Middle Eastern Respiratory 
Syndrome (MERS): pulmonary edema, microthrombi, diffuse alveolar 
damage with hyaline membrane formation (Carsana et al., 2020; Fox 
et al., 2020), and evidence of pneumocyte desquamation suggesting 
the presence or progression to acute respiratory distress syndrome 
(ARDS) (Xu et al., 2020). Importantly, an aberrant healing response 
can promote excessive tissue fibrosis, impair regeneration and re-
modeling, and eventually lead to suboptimal recovery (Mason et al., 
2020).
Lungs, like many other organs, show a progressive decline in 
function with increasing age as a result of structural and physio-
logical changes (Miller et al., 2010). Because the lung is constantly 
exposed to external environmental stressors, it is conceivable that 
lung aging results from a combination of external and internal fac-
tors that increases the risk of chronic lung diseases (Meiners et al., 
2015). Notably, the incidence of degenerative chronic lung diseases, 
namely chronic obstructive pulmonary disease (COPD) and idio-
pathic pulmonary fibrosis (IPF), dramatically rises with age (Meiners 
et al., 2015), and unsurprisingly the elderly have higher morbidity 
and mortality after acute lung injury relative to younger adults 
(Rubenfeld et al., 2005). Different studies have shown that aged 
lungs show uncontrolled inflammatory responses in murine models 
of acute lung injury, including models of viral infection (Kling et al., 
2017; Yin et al., 2014). In addition to imbalanced immune responses, 
defects in tissue maintenance and repair can also play a role in the 
susceptibility to lung damage. It is known that COPD and IPF in-
crease the vulnerability to pneumonia (Raghu et al., 2011; Torres 
et al., 2013). Importantly, patients with lung COPD and IPF show 
an increase in senescence-associated markers, and the removal of 
senescent cells alleviate progression of these pathologies in preclin-
ical mouse models (Parikh et al., 2019). The contribution of cellular 
senescence to lung dysfunction occurs via different cell and non-cell 
autonomous mechanisms. Senescent stem/progenitor cells reduce 
lung regenerative capacity, a major age-associated hallmark in the 
lungs (Hamsanathan et al., 2019; Kathiriya et al., 2020). SASP factors 
IL-6, IL-8, IL-1, and TNF-α might be crucial for chronic inflammation 
(Kumar et al., 2014; Tsuji et al., 2010), while TGF-β, PAI-1, and MMPs 
might contribute to fibrosis (Lomas et al., 2012) and stimulate the 
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expression of fibrotic genes, such as ACTA2, COL1A1, COL1A2, and 
FN1, in surrounding non-senescent cells (Schafer et al., 2017).
3.2  |  Contribution of senescence to multi-
morbidity
COVID-19 is often a multi-organ disease. SARS-CoV-2 replication 
occurs in tissues outwit the lung, including the intestinal and renal 
epithelium (Chu et al., 2020) and is well recognized to be associated 
with clinical manifestations including but not limited to, diarrhea, 
derange liver function tests, kidney and brain dysfunction. Notably, 
symptom complexes dominated by joint and muscle pain or gastro-
intestinal disturbance rather than respiratory symptoms (such as 
cough) have been described (Docherty et al., 2020). In addition to 
impaired oxygenation due to lung syndromes, multi-organ failure is 
usually observed in severe COVID-19 cases (Guan et al., 2020), par-
ticularly those in Intensive Care Units.
The direct cause of multi-organ failure in COVID-19, as in other 
critical illnesses, is not clear but the major contributors are likely 
to be the direct viral infection, and an excessive immune response, 
mainly as a result of the cytokine storm (Li et al., 2020).
Systemically, microvasculature dysfunction is common in in-
fected patients (Varga et al., 2020), with abnormal coagulation and 
thrombosis observed at late disease stages and associated to poor 
prognosis (Tang et al., 2020). Aberrant coagulation is due to endo-
thelial activation and damage but can lead to damage in multiple 
tissues, increase cardiovascular events, and cause pulmonary em-
bolism (Connors & Levy, 2020; Escher et al., 2020). Identified risk 
factors for vascular dysfunction are aging, obesity, diabetes, and 
hypertension—conditions associated to severe reactions to SARS-
CoV-2 infection and by high number of senescent cells. Accumulating 
evidences suggest that cellular senescence plays an important role 
in vascular dysfunction. As mentioned before, SASP factors such 
as IL-6 can help amplify SARS-CoV-2—driven inflammation. It is 
interesting to note that soluble IL-6 receptor (sIL-6R) is part of the 
SASP (Garbers et al., 2013). sIL-6R activates IL-6 signaling in cells 
that do not express membrane-bound IL-6 receptor (mIL-6R), such 
as endothelial cells. This can lead to the activation of IL-6 signaling 
in different types of cells, with consequent exacerbation of the in-
flammatory response, but also to senescence propagation (Kojima 
et al., 2013). Along with inflammatory factors, it has been shown 
that senescent cells secret different hemostasis-related factors that 
favor clotting (Wiley et al., 2019). Endothelial senescent cells can 
promote a prothrombotic state via upregulation of factors that in-
duce platelet aggregation (e.g., PAI-1, thromboxane A2, and vWF), 
and downregulation of factors that inhibit aggregation (e.g., eNOS, 
prostacyclin, and thrombomodulin) (Bochenek et al., 2016). Thus, 
cellular senescence might elevate the risk for thrombosis by shifting 
the balance between anti- and procoagulant pathways. Furthermore, 
senescent endothelial cells have an impaired barrier integrity and re-
duced tight junctions (Krouwer et al., 2012; Yamazaki et al., 2016). 
Vascular regeneration might be an essential factor in recovery and 
prevention of damage progression in response to infection. Cellular 
senescence can alter the repair capacity of the endothelium and 
decrease angiogenesis through the impairment of proliferation and 
function of endothelial progenitor cells thus leading to persistent 
damage (Ungvari et al., 2018). Cellular senescence is also linked to 
pulmonary hypertension (Feen et al., 2019), which could potentially 
restrict blood flow to the lungs and induce capillary damage even-
tually leading to hypoxemia and ARDS. Interestingly, endothelial 
cells might be induced to senescence by SARS-CoV-2 infection. The 
binding of SARS-CoV-2 to ACE2 receptor and subsequent entry can 
lead to the suppression of the activity of this enzyme. This can result 
in decreased Ang-(1–7) generation, and consequently increased Ang 
II levels (South et al., 2020). Increased activity of ACE–Ang II axis 
relative to that of ACE2–Ang-(1–7) axis might help driving cellular se-
nescence, especially in the vascular system (Mogi et al., 2020). Taken 
together, high level of vasculature senescence, either already pres-
ent at time of infection or induced by the reaction to SARS-CoV-2, 
can contribute to the exaggerate vascular dysfunction observed in 
severe cases of COVID-19.
Myocardial dysfunction is common in COVID-19 with the cardiac 
myocytes being involved in the infectious process in SARS (Oudit 
et al., 2009) and SARS-CoV-2 (Wang et al., 2020). Cardiac troponins, 
a marker of cardiac myocyte damage are frequently elevated in 
COVID-19 and are a marker of poor prognosis (Guo et al., 2020). 
Cellular stress in cardiac myocytes has been associated with a raft 
of molecular markers of senescence (Kajstura et al., 2000; Sheydina 
et al., 2011) and are themselves associated with impaired cardiac 
function. Acute cardiac damage promotes mesenchymal senescence 
and fibrosis (Zhu et al., 2013). Similarly, chronic cardiac disease 
may have associations with the establishment of senescence in the 
heart (Shimizu & Minamino, 2019), particular of cardiac fibroblasts. 
Functional studies depleting senescent cells have linked the senes-
cence to perpetuation of atherosclerosis and cardiac fibrosis forma-
tion (Childs et al., 2018).
Vascular complications in late disease may promote or worsen 
damage to other organs. However, it is notable that some organs 
which may not be directly infected by the virus are often affected 
early during the disease. For example, abnormal liver function 
tests are present in up to three quarters of patients with COVID-
19 infection with their elevation being associated with poor patient 
outcomes (Cai et al., 2020). These abnormalities are typically ele-
vated levels of hepatocyte-specific transaminases (ALT and AST). 
Hepatocytes, unlike other cells in the liver and the bile ducts, are not 
themselves directly tropic to the virus, so their damage appears to 
be an indirect event. While vascular phenomena in COVID-19 may 
contribute to this (McGonagle et al., 2020), deranged liver function 
tests may be seen in other forms of systemic illness, including sep-
sis, and may affect liver function via hepatocyte damage and indi-
rect tissue injury (Roelofsen et al., 1994; Yan et al., 2014). Acute or 
chronic tissue damage in hepatocytes is sufficient to induce a senes-
cence-like state (Aravinthan & Alexander, 2016; Bird et al., 2018). 
The liver was the first organ in which senescence was shown to be 
capable of paracrine spread between tissue epithelium in vivo, both 
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between hepatocytes (Bird et al., 2018) and between the biliary tree 
and hepatocytes (Ferreira-Gonzalez et al., 2018). Whether cellular 
senescence may be spread in an endocrine manner during COVID-
19, both within and between tissues, remains to be established. 
Similarly, if the presence of a underlying senescence burden in tis-
sues predisposes to the establishment of the sort of positive feed-
back that drives senescence spread within the liver through TGF-β 
(Bird et al., 2018) is worthy of further investigation.
Elderly patients with severe cases of COVID-19 are also more 
likely to experience a host of neurological symptoms, suggestive 
of central nervous system infection, including impaired conscious-
ness and loss of smell (Mao et al., 2020; Yan et al., 2020). During the 
2003 SARS outbreak evidence of neural tissue infection was found 
(Hamming et al., 2004; Xu et al., 2005; Zhou et al., 2020). A recent 
report has found evidence of the SARS-CoV-2 virus also appearing 
in cerebrospinal fluid, but how the virus enters this protected tissue 
is currently unknown (Wu et al., 2020a). Vascular cells of the blood-
brain barrier that help isolate the CNS from infection can become 
senescent and contribute to functional decline of the structure with 
age (Yamazaki et al., 2016). Interestingly, some patients showed 
neurological symptoms before pulmonary features, suggesting the 
possibility of infection via an alternative route involving the nervous 
tissue (Mao et al., 2020). Progression of age-associated senescence 
in the blood-brain barrier may therefore be an important factor in 
CNS infection and disease severity in elderly COVID 19 patients.
It is essential to note that, depending on the severity of the 
disease, recovered patients might develop long-term health con-
sequences (Chiumello et al., 2016; Inciardi et al., 2020; Wu et al., 
2020b). Previous SARS-CoV and MERS-CoV epidemics were both 
associated with significant incidence of long-term fibrotic lung dis-
ease as well as involvement of other organs (Das et al., 2017; Ong 
et al., 2004; Zhang et al., 2020). Early reports have suggested evi-
dence of impaired lung function in patients recovering from SARS-
CoV-2. As it is presented, SARS-CoV-2 infection has the potential 
to promote senescence spread across different tissues in multiple 
ways. Accumulation of senescent cells after infection might predis-
pose individuals to premature aging in different organs, contributing 
to long-term consequences and accelerating numerous age-related 
pathologies. Therefore, evaluating the presence and role of senes-
cence caused by viral infection might represent an important predic-
tor for the consequences of long-term damage.
4  |  CONTRIBUTION OF CELLUL AR 
SENESCENCE TO VACCINATION
Reduced vaccine efficacy in the elderly is a concern as COVID-19 
vaccines enter clinical trials. Evidence is mounting that both humoral 
and cellular immunity is critical in battling COVID-19 (Tay et al., 2020). 
Bridging the gap between cellular senescence and adaptive immu-
nity are a group of stress-inducible proteins called sestrins that play 
a direct regulatory role in T cells that have acquired senescent-like 
features. Sestrin expression in senescent-like CD4+ T cells impaired 
AMPK signaling and T-cell function through a novel ERK/JNK/p38 
MAPK activation pathway. Sestrin knockdown partially reversed 
the senescent-like phenotype and enhanced T-cell responsiveness 
in vitro, while Sestrin knock-out mice were able to produce higher 
antibody titer against influenza infection, demonstrating a critical 
function in overall immune response (Lanna et al., 2017). Similarly, 
expression of Sestrin impairs CD8+ senescent-like T cells activity by 
blocking TCR signaling and shifting effector activity toward an NK 
cell-like phenotype. Conversely, down-regulating Sestrin expression 
in these cells resulted in partial recovery of T-cell function and co-
incided with the disappearance of NK cell ligand receptors NKG2A 
and NKG2D. In this way, cellular senescence might directly drive a 
shift away from adaptive immunity toward innate immune responses 
in the elderly with important implications for vaccine development 
(Pereira et al., 2020). Senescent-like B cells expressing p16 and 
constitutively secrete a SASP-like profile including TNF-α and IL-6 
also appear in older organisms (Frasca et al., 2017). Experiments 
show that TNF-α reduces B-cell class switching and hypermuta-
tion required for high-affinity antibody generation and that block-
ing TNF-α with antibodies improved B-cell activation (Frasca et al., 
2014; Signer et al., 2008). Autocrine and Paracrine effects of TNF-α 
signaling among circulating B cells suggests that as senescent-like 
B cells accumulate, the overall population effector function will be 
diminished. Even more fundamentally, the spatiotemporal regulation 
of B-cell development in the bone marrow arises from a complicated 
interplay of chemokine and cytokine gradients between bone mar-
row cellular niches. CXCL-12 is a chemokine that participates in this 
gradient and directs developing B-cell migration (Tokoyoda et al., 
2004). Expression of CXCL-12 can be seen in senescent stromal cells 
cultured from old mice and is ameliorated with ABT263 (Kim et al., 
2017). This aberrant regulation of CXCL-12 may degrade the optimal 
cellular niche gradient, affecting B-cell fate and function by reducing 
compartmentalization of early precursor B cells, and interfering with 
B-cell migration from the bone marrow.
DNA-based vaccines for use against COVID-19 are already en-
tering clinical trials (ClinicalTrials.gov Identifier: NCT04336410). 
Compared to traditional vaccines, they have the advantage of being 
quick to develop and rapidly scalable at cost. These vaccines par-
tially depend on antigen presentation on MHC class I molecules by 
somatic cells transfected with DNA vectors encoding viral proteins. 
CD8+ T-cell detection of expressed viral antigens is an important 
element of DNA-vaccine efficacy, as well as innate NK cell activity 
(Ahmad et al., 2012; Zhu et al., 2011). DNA-Vaccines are adminis-
tered to skin or muscle tissue, both of which display an accumulation 
of senescent cells with age (Waaijer et al., 2012; Wang et al., 2009) 
that may interfere with vaccine efficacy. In dermal tissue, senescent 
skin cells display upregulation of surface HLA-E proteins that inhibit 
co-stimulatory NKG2A receptors on both NK cells and CD8+ T cells, 
impeding immune cell activation (Pereira et al., 2019). Additionally, 
immune cell-stimulating NKG2D ligands present on transfected 
cells are suppressed in senescent cells by autocrine MMP proteo-
lytic cleavage (Lanier et al., 2015; Munoz et al., 2019). Furthermore, 
MMPs are part of the SASP and may diffuse into surrounding tissue 
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F I G U R E  2 Effects	of	cellular	senescence	on	different	body	systems	might	increase	the	risk	for	developing	severe	COVID-19.	Various	
factors can induce multi-tissue accumulation of senescent cells. Cellular senescence can lead to immune imbalance, including weak adaptive 
immunity and exaggerated inflammatory response. In lungs, senescence can decrease regenerative capacity and enhance aberrant healing 
response and tissue fibrosis. Vascular function is also known to be highly affected by cellular senescence through different mechanisms 
including increased thrombotic and inflammatory responses and decreased regeneration
TA B L E  1 List	of	selected	COVID-19	trials	using	potential	senotherapeutics
Studiesa  Drug Enrollmenta  Senescence-related target Study identifier
110/51 Tocilizumab
Sarilumabb 
N	=	≤5000 IL6-Receptor/SASP inhibitor IRCT20151227025726N13
NCT04315298








2 Ruxolitinib N	=	≥50 JAK/STAT inhibitor IRCT20160310026998N11 
IRCT20131129015584N2
2 Sirolimusb  N	=	≥50 mTOR/SASP inhibitor NCT04371640
NCT04341675
1 Metformin N = 200 AMPK activators/SASP inhibitor IRCT20160310026998N11
1 Quercetinb  N = 50 PI3K/AKT/P53/Serpine/ HIF-1 α NCT04377789
aData collection: https://www.covid -trials.org/. 
bNot completed studies. 
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further dampening NKG2D signaling. DNA-vaccine immunogenicity 
also relies on a STING-driven type I IFN induction pathway and acti-
vation of innate and CD8+ T cells (Suschak et al., 2016). As senescent 
cells already display constitutive STING activation (Dou et al., 2017) 
while evading immune detection, it is likely that DNA-vaccination 
will generate only marginal immunogenicity in these cells by this 
mechanism. Senescent cells may therefore act as DNA vector de-
coys in the elderly; and dampen antigen-specific immune response.
5  |  FUTURE OUTLOOK: CELLUL AR 
SENESCENCE A S BIOMARKER AND TARGET 
FOR COVID -19
High burst of senescence is normally observed in older individu-
als, which are by far the most likely to develop severe-to-lethal 
COVID-19, and can be caused by direct and indirect virus-mediated 
mechanisms (Figure 1). Senescent cells might contribute to severe 
reactions to SARS-CoV-2 by provoking immune imbalance and by 
mediating local and distant damage (Figure 2). Thus, measuring the 
abundance of senescent cells can serve as a biomarker to predict for 
COVID-19 severity, while targeting senescence-associated mecha-
nisms prior and after SARS-CoV-2 infection has the potential to limit 
severe and even lethal damages. Moreover, reduction of senescence 
might also improve the efficacy of vaccinations.
Measuring senescence in human tissues remains a challenging 
task. In recent years, it has become evident that the senescence phe-
notype is highly heterogenous, and neither a specific nor a universal 
senescent marker exists (Hernandez-Segura et al., 2018). However, 
tissue levels of the CDK4/6 inhibitor p16INK4A or of the lysosomal 
senescence-associated β-galactosidase could be used as a surrogate 
tool for measuring senescence (Gorgoulis et al., 2019).
Because of the recognized detrimental effects of senescent cells 
in various age-related disorders, there has been an exponential inter-
est in the development of senotherapies. Senotherapies are based 
on compounds able to either eliminate senescent cells (senolytics) 
or interfere with aspects of senescence such as the SASP (senos-
tatics). Senotherapies have recently entered clinical trials, and two 
strategies—the combination of the protein kinase inhibitor Dasatinib 
with the flavonoid Quercetin (D + Q) and UBX0101, a compound 
disrupting the interaction between Mdm2 and p53—have shown tol-
erability and a safe profile. Interestingly, compounds with predicted 
senolytic or senostatic properties are currently in clinical trials for 
COVID-19 (Table 1): quercetin, shown to be senolytic in various pre-
clinical models (Russo et al., 2020), is tested as prophylactic treat-
ment; anakinra, tocilizumab, pirfenidone, and ruxolitinib, all shown 
to have the capacity to inhibit parts of the SASP (Hubackova et al., 
2012; Laberge et al., 2015; Orjalo et al., 2009; Rodier et al., 2009; 
Soto-Gamez & Demaria, 2017), are used to treat the hyperinflamma-
tory syndrome associated with severe COVID-19 disease; sirolimus, 
an mTOR inhibitor which can reduce SASP and prevent senescence 
induction (geroconversion) (Blagosklonny et al., 2018; Laberge et al., 
2015), is tested as treatment against SARS-CoV-2 spread and it is 
thought to prevent severe progression in COVID-19 (Omarjee et al., 
2020); metformin, an anti-diabetic drug that activates AMPK and 
lower NFkB leading to SASP reduction (Moiseeva et al., 2013), is 
tested as an intervention against the acute respiratory syndrome.
Based on these concepts, evaluation of senescence markers 
should be considered in treated and non-treated COVID-19 patients 
and at different time points during and after SARS-CoV-2 infection. 
This information can shed light on the potential to use the burst of 
cellular senescence as a biomarker to predict disease severity, but 
also as a pharmacological target to reduce the short- and long-term 
consequences of the disease.
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